# Lowering Viral Load With Nucleos(T)Ide Analogues Prior to Peginterferon Treatment to Ncrease Sustained Response in CHB

> **NCT01532843** · PHASE4 · COMPLETED · sponsor: **Foundation for Liver Research** · enrollment: 82 (actual)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** PegIFN alfa-2b

## Key facts

- **NCT ID:** NCT01532843
- **Lead sponsor:** Foundation for Liver Research
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2019-01-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01532843

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01532843, "Lowering Viral Load With Nucleos(T)Ide Analogues Prior to Peginterferon Treatment to Ncrease Sustained Response in CHB". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01532843. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*